Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Minimally Invasive Glaucoma Surgery (MIGS) Devices Market covers analysis By Surgery (Glaucoma in Conjunction with Cataract, Stand-Alone Glaucoma); Target (Trabecular Meshwork, Suprachoroidal Space, Others); Product (MIGS Stents, MIGS Shunts, Other); End User (Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00014218
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Minimally invasive glaucoma surgery (MIGS) devices are used in glaucoma surgery that avoids conjunctival dissection and includes an internal incision for the treatment of patients suffering from glaucoma. The appearance of MIGS devices has transformed the patient's care with mild-to-moderate glaucoma conditions.

MARKET DYNAMICS



Growing burden of geriatric population and rise in demand for surgeries combining glaucoma and cataract is likely to boosts the market growth. However, unfavorable reimbursement for minimally invasive glaucoma surgery devices is anticipated to hamper the market growth.

MARKET SCOPE



The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of minimally invasive glaucoma surgery (MIGS) devices market with detailed market segmentation by surgery, target, product and end user. The minimally invasive glaucoma surgery (MIGS) devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in minimally invasive glaucoma surgery (MIGS) devices market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The minimally invasive glaucoma surgery (MIGS) devices market is segmented on the basis of surgery, target, product and end user. Based on surgery, the market is segmented as glaucoma in conjunction with cataract and stand-alone glaucoma. On the bases of target, the market is segmented as trabecular meshwork, suprachoroidal space, and others. By product is further segmented as MIGS stents, MIGS shunts and other. Based on end user, the market is segmented as Eye hospitals, ophthalmology clinics, and outpatient surgical centers.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the minimally invasive glaucoma surgery (MIGS) devices market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The minimally invasive glaucoma surgery (MIGS) devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting minimally invasive glaucoma surgery (MIGS) devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the minimally invasive glaucoma surgery (MIGS) devices market in these regions.

MARKET PLAYERS



The report covers key developments in the minimally invasive glaucoma surgery (MIGS) devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as type launches, type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from minimally invasive glaucoma surgery (MIGS) devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for minimally invasive glaucoma surgery (MIGS) devices in the global market. Below mentioned is the list of few companies engaged in the minimally invasive glaucoma surgery (MIGS) devices market.

The report also includes the profiles of key players in minimally invasive glaucoma surgery (MIGS) devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  NOVARTIS INTERNATIONAL AG
  •  ALLERGAN PLC.
  •  ELLEX MEDICAL LASERS LTD.
  •  GLAUKOS CORPORATION
  •  ISTAR MEDICAL SA
  •  IVANTIS INC.
  •  LUMENIS LTD.
  •  SANTEN PHARMACEUTICAL CO LTD
  •  SOLX, INC.
  •  TOPCON CORPORATION

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Surgery
  • Glaucoma in Conjunction with Cataract
  • Stand-Alone Glaucoma
By Target
  • Trabecular Meshwork
  • Suprachoroidal Space
By Product
  • MIGS Stents
  • MIGS Shunts
By End User
  • Eye Hospitals
  • Ophthalmology Clinics
  • Outpatient Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • NOVARTIS INTERNATIONAL AG
  • ALLERGAN PLC.
  • ELLEX MEDICAL LASERS LTD.
  • GLAUKOS CORPORATION
  • ISTAR MEDICAL SA
  • IVANTIS INC.
  • LUMENIS LTD.
  • SANTEN PHARMACEUTICAL CO LTD
  • SOLX, INC.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    minimally-invasive-glaucoma-surgery-migs-devices-market-report-deliverables-img1
    minimally-invasive-glaucoma-surgery-migs-devices-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. NOVARTIS INTERNATIONAL AG
    2. ALLERGAN PLC.
    3. ELLEX MEDICAL LASERS LTD.
    4. GLAUKOS CORPORATION
    5. ISTAR MEDICAL SA
    6. IVANTIS INC.
    7. LUMENIS LTD.
    8. SANTEN PHARMACEUTICAL CO LTD
    9. SOLX, INC.
    10. TOPCON CORPORATION
    minimally-invasive-glaucoma-surgery-migs-devices-market-cagr